Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 6,381–6,400 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Nicotinamide Adenine Dinucleotide (PF) Injection, NICOTINAMIDE ADENINE DINUCLEOTIDE (PF) 50 MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 10 mL Single Use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0306-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Mitomycin-C (PF) Irrigation Solution, MITOMYCIN-C (PF) 0.5 MG/ML PF SYRINGE, For Intravesicular Use, Freeze, Cytoxic Agent, Preservative Free, Protect From Light, 80 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0812-8

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

MIC-PLUS Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM Use, Refrigerate, Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0231-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

MIC-PLEX Injection, Vitamin Complex, MIC-COMBO* 25MG/50MG/50MG/1MG/20MG/5MG/ML INJECTABLE, For IM Use, Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0233-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

MIC-B12 Injection, MIC-B12 25MG/50MG/50MG/1MG/ML INJECTABLE, For IM Use, Refrigerate. Protect From Light, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0230-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 50 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0636-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE [10ML] CMC 100 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0619-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Methylprednisolone Acetate Injectable Suspension, METHYLPREDNISOLONE ACETATE (PF) CMC [2ML] 80 MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0639-2

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Methylprednisolone Acetate/Bupivacaine Hydrochloride Injectable Suspension, METHYLPRED ACETATE/BUPIVACAINE HCL [10ML] CMC 80MG/5MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0624-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Methylprednisolone Acetate/Bupivacaine Hydrochloride Injectable Suspension, METHYLPRED ACETATE/BUPIV [10ML] CMC 40MG/5MG/ML INJ SUSP, For IM, IA Use, Shake Well, 10 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0623-1

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Methylcobalamin Injection, METHYLCOBALAMIN 1 MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0331-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Methylcobalamin Injection, METHYLCOBALAMIN [CD] 10MG/100MG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0338-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Methionine/Inositol/Choline Injection, METHIONINE/INOSITOL/CHOLINE 25MG/50MG/50MG/ML INJECTABLE, For IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0215-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass III

Magnesium Chloride Injection, MAGNESIUM CHLORIDE 20% INJECTABLE, For IV Use, 50 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0225-5

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Lysine Hydrochloride Injection, LYSINE HCL 100MG/ML INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0342-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Lidocaine HCL (PF) Injection, LIDOCAINE HCL 4% (PF) 40 MG/ML INJECTABLE, For ocular injection, Preservative free, discard unused portion, protect from light, 5 mL Single-use Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-1011-5

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Levocarnitine Injection, LEVOCARNITINE 500 MG/ML INJECTABLE, For IV Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-9260-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Polyoxyl Lauryl Ether (Polidocanol) Injection, LAURETH-9 (POLIDOCANOL) 5% INJECTABLE, For IV Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-060-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Arginine Hydrochloride Injection, L-ARGININE HCL 100MG/ML INJECTABLE, For IV, IM Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0341-3

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Drug Recall Terminated Historical recordClass II

Hydroxyprogesterone Caproate Injection, HYDROXYPROGESTERONE CAPROATE [4ML] 250 MG/ML INJECTABLE, For IV, IM Use, Refrigerate, 4 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0532-5

by Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical

Reason
Lack of Assurance of Sterility
Recall initiated
January 15, 2020
Reported by FDA
March 11, 2020
Distribution
U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.